Anticancer agent 33 (compound 3), derived from Squamocin and Bullatacin, exhibits potent inhibitory activity against the 4T1 breast cancer cell line (A549, HeLa, HepG2, and MCF-7 cells) with IC50 values ranging from 1.9 to 5.4 µM [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
